Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) jumped 13.6% in the afternoon session after the company provided strong 2026 financial guidance that surpassed analyst ...
ANI Pharmaceuticals (ANIP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results